Patients with systemic lupus erythematosus, myositis, rheumatoid arthritis and scleroderma share activation of a common type I interferon pathway
暂无分享,去创建一个
S. Greenberg | W. White | P. Kiener | Wei Zhu | B. Jallal | D. Fiorentino | C. Morehouse | Yihong Yao | B. Higgs | L. Richman | B. White | Zheng Liu | P. Brohawn | P. Brohawn